Alzheimer’s disease is the most frequent cause of dementia, contributing to up to 70 percent of dementia cases. Worldwide, approximately 24 million people are affected, and this number is expected to double every 20 years. Owing to societal aging, the disease will become a costly public health burden in the years to come. The global artificial intelligence (ai) in alzheimer market is likely to register a CAGR of over 18.6% with an incremental growth of USD 186 million during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global artificial intelligence (ai) in alzheimer market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the artificial intelligence (ai) in alzheimer industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, application, and region. The global market for artificial intelligence (ai) in alzheimer can be segmented by type: machine learning (ML), natural language processing (NLP). The machine learning (ML) segment held the largest revenue share in 2021. Artificial intelligence (ai) in alzheimer market is further segmented by application: diagnosis, research, therapy, others. Based on region, the artificial intelligence (ai) in alzheimer market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By type:
– machine learning (ML)
– natural language processing (NLP)

By application:
– diagnosis
– research
– therapy
– others

By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)

The market research report covers the analysis of key stake holders of the global artificial intelligence (ai) in alzheimer market. Some of the leading players profiled in the report include Exscientia Ltd., GlaxoSmithKline plc, International Business Machines Corporation (IBM), Moderna, Inc., Pfizer Inc., Sanofi S.A., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global artificial intelligence (ai) in alzheimer market.
– To classify and forecast the global artificial intelligence (ai) in alzheimer market based on type, application, region.
– To identify drivers and challenges for the global artificial intelligence (ai) in alzheimer market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global artificial intelligence (ai) in alzheimer market.
– To identify and analyze the profile of leading players operating in the global artificial intelligence (ai) in alzheimer market.

Why Choose This Report
– Gain a reliable outlook of the global artificial intelligence (ai) in alzheimer market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.